Israeli Air Purifier Could Bring Japan’s Karaoke Industry Back to Life Maya Margit 12/23/2020
Aura Air signs $30 million deal to supply Japanese market with air purifying system, which has proven to be 99.99% effective in killing COVID-19
An air filtration and disinfection system developed in Israel that kills viruses could bring Japan’s ailing karaoke industry back to life.
Tel Aviv-based startup Aura Air has signed a $30 million deal with Japanese distributor J-TEC to supply the Japanese market with its advanced technology, which is specially designed to purify air in closed spaces. The company’s system has proven to be 99.99% effective at eliminating COVID-19 particles, among other pathogens.
Thousands of Israelis Take to The Streets to Protest Netanyahuâs Corruption Published December 20th, 2020 - 11:40 GMT
Israeli Prime Minister Benjamin Netanyahu wears a protective mask after receiving a coronavirus vaccine at the Sheba Medical Center, the country s largest hospital, in Ramat Gan near the coastal city of Tel Aviv, on December 19, 2020. Netanyahu, 71, and Israel s health minister were injected with the Pfizer-BioNTech vaccine live on TV at Sheba Medical Center. Each recipient must receive a booster shot in three weeks for optimal protection from the novel coronavirus. JACK GUEZ / AFP
Highlights
Meanwhile, several pro-Netanyahu demonstrators are also attending another rally, holding up signs that read Traitorous Leftists and Enemy Leftists.
Israel approves start of phase two clinical trials for COVID-19 vaccine clevelandjewishnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clevelandjewishnews.com Daily Mail and Mail on Sunday newspapers.
Vials of the experimental COVID-19 vaccine from the Israel Institute for Biological Research.
Israelâs Health Ministry has approved the start of the second phase of clinical trials for the Israel Institute for Biological Researchâs (IIBR) COVID-19 vaccine, following the successful completion of the first phase, according to a Defense Ministry statement.
The second-phase trial, which will involve testing some 1,000 healthy volunteers aged 18 and over, is expected to begin in the coming days. In this phase, scientists aim to determine safety, efficacy and dosages. Its success will enable a large-scale trial with the participation of up to 30,000 volunteers (Phase 3) in Israel and/or abroad.
Hospital staff provide medical care for patients at a coronavirus disease (COVID-19) ward, amid a surge in new cases that has forced Israel into a second nationwide lockdown, at Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel, Sept. 21, 2020. Photo: Reuters / Ronen Zvulun.
JNS.org– An Israeli startup’s groundbreaking innovation may provide a much-needed remedy to the shortage of ventilators and the overwhelming of staff in COVID-19 wards.
“Yehonatan Medical, in collaboration with professor Ori Efrati, director of the Pediatric Pulmonary Unit at the Sheba Medical Center at Tel HaShomer, devised a state-of-the-art, first-of-its-kind ventilation system that can treat between three and five patients simultaneously. That means more patients treated by fewer ICU staff,” the company said in a statement.